Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/GFM210PMID 17724037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production.

  2006cited by this paper
• Circulating PTH molecular forms: what we know and what we don't.

  2006cited by this paper
• Profound mishandling of protein glycation degradation products in uremia and dialysis.

  2005influential reference
• Chronic kidney disease as cause of cardiovascular morbidity and mortality.

  2005cited by this paper
• Removal of P-cresol sulfate by hemodialysis.

  2005cited by this paper
• Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum.

  2005cited by this paper
• Modification of leukocyte response by phenolic protein-bound uremic retention solutes

  2005cited by this paper
• Stereospecific and Redox-Sensitive Increase in Monocyte Adhesion to Endothelial Cells by Homocysteine

  2005cited by this paper
• New insights in uremic toxins.

  2003cited by this paper
• Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.

  2003influential reference
• Uraemic toxins and cardiovascular disease.

  2003cited by this paper
• Review on uremic toxins: classification, concentration, and interindividual variability.

  2003cited by this paper
• Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin.

  2002cited by this paper
• Plasma reduced homocysteine concentrations are increased in end-stage renal disease.

  2001cited by this paper
• Uremic Toxicity: Present State of the Art

  2001cited by this paper
• Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils.

  2000influential reference
• Increase in Three α,β-Dicarbonyl Compound Levels in Human Uremic Plasma: Specificin VivoDetermination of Intermediates in Advanced Maillard Reaction

  1999cited by this paper
• Metformin reduces systemic methylglyoxal levels in type 2 diabetes.

  1999cited by this paper
• Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction.

  1999cited by this paper
• Mass spectrometric study on the protein chemical modification of uremic patients in advanced Maillard reaction.

  1999influential reference
• Genesis of the uraemic syndrome: role of uraemic toxins.

  1998cited by this paper
• Genesis of the uraemic syndrome: role of uraemic toxins.

  1998cited by this paper
• Role of the Maillard Reaction in Aging of Tissue Proteins

  1998cited by this paper
• Detection and quantification of pentosidine in foods

  1997influential reference
• Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.

  1997cited by this paper
• Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct.

  1997influential reference
• The serum concentration of the advanced glycation end-product Nε-(carboxymethyl)lysine is increased in uremia: Technical Note

  1997cited by this paper
• Synthesis of pyrraline reference material

  1996influential reference
• The effect of folic acid on the homocysteine metabolism in human umbilical vein endothelial cells (HUVECs)

  1996cited by this paper
• First evidence for accumulation of protein-bound and protein-free pyrraline in human uremic plasma by mass spectrometry.

  1996cited by this paper
• Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications.

  1994cited by this paper
• Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.

  1992cited by this paper
• Purification and biochemical characterization of the complete structure of a proteolytically modified beta-2-microglobulin with biological activity.

  1987cited by this paper
• Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides.

  1976cited by this paper
• Le blocage de la lysine par la réaction de Maillard. II. Propriétés chimiques des dérivés N‐(désoxy‐1‐D‐fructosyl‐1) et N‐(désoxy‐1‐D‐lactulosyl‐1) de la lysine

  1972cited by this paper
• [Blockage of lysine by Mallard's reaction. II. Chemical properties of derivatives N-(deoxy-1-D-fructosyl-1) and N-(deoxy-1-D-lactulosyl-1) lysine].

  1972influential reference

• A guide to uraemic toxicity

  2025cites this paper
• Effects of resveratrol on inflammation and oxidative stress induced by the uremic toxin indoxyl sulfate in Murine macrophage-like RAW 264.7.

  2023cites this paper
• Renal function is a major predictor of circulating acyl-CoA-binding protein/diazepam-binding inhibitor

  2023cites this paper
• Polyphenol-rich açaí seed extract exhibits reno-protective and anti-fibrotic activities in renal tubular cells and mice with kidney failure

  2022cites this paper
• Intravital Imaging with Two-Photon Microscopy: A Look into the Kidney

  2022cites this paper
• Uremic toxin indoxyl sulfate induces dysfunction of vascular smooth muscle cells via integrin-β1/ERK signaling pathway

  2022cites this paper
• Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

  2022cites this paper
• The Probe for Renal Organic Cation Secretion (4-Dimethylaminostyryl)-N-Methylpyridinium (ASP+)) Shows Amplified Fluorescence by Binding to Albumin and Is Accumulated In Vivo

  2022cites this paper
• Establishing Cell Models to Understand Cellular Toxicity: Lessons Learned from an Unconventional Cell Type

  2022cites this paper
• The very last dance of unconjugated p-cresol... historical artifact of uremic research...

  2021cites this paper
• High cut-off dialysis mitigates pro-calcific effects of plasma on vascular progenitor cells

  2021cites this paper
• Effects of p-Cresol on Oxidative Stress, Glutathione Depletion, and Necrosis in HepaRG Cells: Comparisons to Other Uremic Toxins and the Role of p-Cresol Glucuronide Formation

  2021cites this paper
• Indoxyl Sulfate Elevated Lnc-SLC15A1-1 Upregulating CXCL10/CXCL8 Expression in High-Glucose Endothelial Cells by Sponging MicroRNAs

  2021cites this paper
• The protein-bound uremic toxin p-cresyl-sulfate promotes intracellular ROS production and lipid peroxidation in 3T3-L1 adipose cells.

  2021cites this paper
• Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome

  2020cites this paper
• Uremic Toxins and Vascular Calcification–Missing the Forest for All the Trees

  2020cites this paper
• Indoxyl Sulfate-Mediated Metabolic Alteration of Transcriptome Signatures in Monocytes of Patients with End-Stage Renal Disease (ESRD)

  2020cites this paper
• Ghent University

  2020cites this paper
• An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances

  2019cites this paper
• Indoxyl sulfate–induced TNF‐α is regulated by crosstalk between the aryl hydrocarbon receptor, NF‐κB, and SOCS2 in human macrophages

  2019cites this paper
• Uraemic toxin‐induced inflammation and oxidative stress in human endothelial cells: protective effect of polyphenol‐rich extract from açaí

  2019cites this paper
• The brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney disease.

  2019cites this paper
• Targeting proinflammatory cytokines ameliorates calcifying phenotype conversion of vascular progenitors under uremic conditions in vitro

  2018cites this paper
• Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update

  2018cites this paper
• Uremic Advanced Glycation End Products and Protein‐Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel‐Like Factor 2

  2018cites this paper
• Long noncoding RNA MANTIS relieved the protein-bound uremic toxin-induced injury on human umbilical vein endothelial cells in chronic kidney disease and end-stage renal disease.

  2018cites this paper
• Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins

  2018cites this paper
• p-Cresyl glucuronide is a major metabolite of p-cresol in mouse: in contrast to p-cresyl sulphate, p-cresyl glucuronide fails to promote insulin resistance

  2017cites this paper
• Anemia among hemodialysis patients; an updated mini-review

  2017cites this paper
• Protein-bound P-cresol inhibits human umbilical vein endothelial cell proliferation by inducing cell cycle arrest at G0/G1.

  2017cites this paper
• Hepatocellular carcinoma in hemodialysis patients

  2017cites this paper
• The uremic toxin methylguanidine increases the oxidative metabolism and accelerates the apoptosis of canine neutrophils.

  2017cites this paper
• Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation

  2017cites this paper
• Microbiota and prebiotics modulation of uremic toxin generation.

  2017cites this paper
• Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.

  2016cites this paper
• The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells

  2016influential citation
• Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome.

  2016cites this paper
• Determination of the binding properties of the uremic toxin phenylacetic acid to human serum albumin.

  2016cites this paper
• Free p-Cresol Alters Neutrophil Function in Dogs.

  2016cites this paper
• High Cut Off Hemodialysis

  2016cites this paper
• Micropartículas: mediadores del daño endotelial en la insuficiencia renal crónica

  2015cites this paper
• An in vitro study of effects of the uremic toxin p-cresol on release of inflammatory cytokines from monocytes

  2015cites this paper
• p-Cresol mediates autophagic cell death in renal proximal tubular cells.

  2015cites this paper
• New Methods and Technologies for Measuring Uremic Toxins and Quantifying Dialysis Adequacy

  2015cites this paper
• Immune disorders in hemodialysis patients.

  2015cites this paper
• Proteomic Investigations into Hemodialysis Therapy

  2015cites this paper
• Dimethylarginines ADMA and SDMA: the real water-soluble small toxins?

  2014cites this paper
• Retention and toxicity of uremic solutes in chronic kidney disease.

  2014cites this paper
• Effect of Indoxyl Sulfate on Oxidative Stress, Apoptosis, and Monocyte Chemoattractant Protein-1 in Leukocytes

  2014cites this paper
• БОЛЕЗНИ ПОЧЕК INDOXYL SULPHATE AT CHRONIC KIDNEY DISEASE

  2014cites this paper
• Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration.

  2013cites this paper
• The uraemic toxin phenylacetic acid contributes to inflammation by priming polymorphonuclear leucocytes.

  2013cites this paper
• Uremia-related oxidative stress in leukocytes is not triggered by β2-microglobulin.

  2013cites this paper
• Guanidino compounds inhibit nitric oxide release in J774A.1 macrophages

  2013cites this paper
• p-Cresyl sulfate promotes insulin resistance associated with CKD.

  2013cites this paper
• Cytotoxic Effects of p-Cresol in Renal Epithelial Tubular Cells

  2013cites this paper
• The Uremic Toxin Indoxyl Sulphate Enhances Macrophage Response to LPS

  2013cites this paper
• P-cresol induces disruption of cardiomyocyte adherens junctions.

  2013cites this paper
• The effects of low-dose Nepsilon-(carboxymethyl)lysine (CML) and Nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function

  2012influential citation
• New High-Cutoff Dialyzer Allows Improved Middle Molecule Clearance without an Increase in Albumin Loss: A Clinical Crossover Comparison in Extended Dialysis

  2012cites this paper
• Immune Dysfunction in Uremia—An Update

  2012cites this paper
• Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications.

  2012cites this paper
• P-cresol, but not p-cresylsulphate, disrupts endothelial progenitor cell function in vitro.

  2012cites this paper
• Uremic Toxins Inhibit Transport by Breast Cancer Resistance Protein and Multidrug Resistance Protein 4 at Clinically Relevant Concentrations

  2011cites this paper
• [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship].

  2011cites this paper
• Effects of spermidine and p-cresol on polymorphonuclear cell apoptosis and function.

  2011cites this paper
• Transport of Free and Peptide‐Bound Glycated Amino Acids: Synthesis, Transepithelial Flux at Caco‐2 Cell Monolayers, and Interaction with Apical Membrane Transport Proteins

  2011cites this paper
• Vascular Damage in Kidney Disease: Beyond Hypertension

  2011cites this paper
• Immune Mechanisms Involved in Cardiovascular Complications of Chronic Kidney Disease

  2010cites this paper
• Chapter 18 – The Pathophysiology of Uremia

  2010cites this paper
• Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst.

  2010cites this paper
• Circulating Plasma Antioxidants, Inflammatory Markers and Asymptomatic Carotid Atherosclerosis in End-Stage Renal Disease Patients: A Case Control Study

  2010cites this paper
• Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation

  2010cites this paper
• Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes.

  2009cites this paper
• Considerations in the statistical analysis of hemodialysis patient survival.

  2009cites this paper
• Increased Plasma and Endothelial Cell Expression of Chemokines and Adhesion Molecules in Chronic Kidney Disease

  2009cites this paper
• Cross-membrane flux is a major factor influencing dialysis patient outcomes.

  2008cites this paper
• New insights into uremic toxicity

  2008cites this paper
• Uremic Toxins: Do We Know Enough to Explain Uremia?

  2008cites this paper
• From uremic toxin retention to removal by convection: do we know enough?

  2008cites this paper
• A bench to bedside view of uremic toxins.

  2008cites this paper
• Characteris Tics and Causes of Immune Dysfunction Related to Uremia and Dialysis

  2008cites this paper
• Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies

  2007cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper